TP53 mutations among molecular subtypes of HER2-positive tumors

被引：0
|
作者：
Å Helland
M Nicolau
Y Ji
A Langerød
DE Sommervoll
A Bergamaschi
JR Pollack
A-L Børresen-Dale
SS Jeffrey
机构：
[1] The Norwegian Radium Hospital,Department of Oncology
[2] The Norwegian Radium Hospital,Department of Genetics
[3] Stanford University School of Medicine,Department of Surgery
[4] Statistics Norway,Department of Research
[5] Stanford University School of Medicine,Department of Pathology
来源：
Breast Cancer Research | / 7卷
关键词：
Breast Carcinoma; Molecular Subtype; TP53 Mutation; Ductal Breast Carcinoma; Expression Threshold;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Molecular profiling of bladder tumors based on the detection of FGFR3 and TP53 mutations
    Lamy, A.
    Gobet, F.
    Laurent, M.
    Blanchard, F.
    Varin, C.
    Moulin, C.
    Andreou, A.
    Frebourg, T.
    Pfister, C.
    JOURNAL OF UROLOGY, 2006, 176 (06): : 2686 - 2689
  • [22] TP53 and CHEK2 germline mutations in malignant solid tumors.
    Zhang, Zhiye
    Wu, Yaqing
    Luo, Ningning
    Zhang, Qin
    Han, Tiantian
    Bu, Xuesong
    Shuai, Qin
    Qi, Yingxue
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [23] Molecular characteristics of novel germline mutations in TP53 in Sweden
    Kharaziha, P.
    Larsson, C.
    Tham, E.
    Bajalica-Lagercrantz, S.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 606 - 607
  • [24] TP53 mutations and loss of heterozygosity of chromosome 17 in colorectal tumors
    Yamamoto, L
    Lopes, AA
    HarbGama, A
    Nagai, MA
    BRAZILIAN JOURNAL OF GENETICS, 1996, 19 (04): : 647 - 653
  • [25] Molecular subtypes among HER2 positive tumors defined by expression profiling.
    Nicolau, HÅM
    Ji, Y
    Langerod, A
    Funari, VA
    Sommervoll, DE
    Pollack, JR
    Borresen-Dale, AL
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S215 - S215
  • [26] Clinicopathologic Characteristics of Brain Tumors are Associated with the Presence and Patterns of TP53 Mutations: Evidence from the IARC TP53 Database
    Salnikova, Lyubov E.
    NEUROMOLECULAR MEDICINE, 2014, 16 (02) : 431 - 447
  • [27] Clinicopathologic Characteristics of Brain Tumors are Associated with the Presence and Patterns of TP53 Mutations: Evidence from the IARC TP53 Database
    Lyubov E. Salnikova
    NeuroMolecular Medicine, 2014, 16 : 431 - 447
  • [28] Association between the founder brazilian TP53 p.R337H mutation and HER2-positive status.
    Giacomazzi, Juliana
    Graudenz, Marcia S.
    Osorio, Cynthia A. B. T.
    Koehler-Santos, Patricia
    Palmero, Edenir Inez
    Depieri Michelli, Rodrigo Augusto
    Fernandes, Gabriela Carvalho
    Neto, Cristovam Scapulatempo
    Waddington Achatz, Maria Isabel
    Martel-Planche, Ghyslaine
    Soares, Fernando A.
    Caleffi, Maira
    Goldim, Jose Roberto
    Hainaut, Pierre
    Camey, Suzi Alves
    Ashton-Prolla, Patricia
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [29] TP53 mutations in myelodysplastic syndrome
    Misawa, S
    Horiike, S
    LEUKEMIA & LYMPHOMA, 1996, 23 (5-6) : 417 - 422
  • [30] Landscape of TP53 Mutations in MPN
    Farnoud, Noushin
    Famulare, Christopher
    Papaemmanuil, Elli
    McGovern, Erin
    Medina, Juan
    Ossa, Juan E. Arango
    Rampal, Raajit K.
    Li, Bing
    Levine, Ross L.
    Mascarenhas, John
    Weinberg, Rona Singer
    Patel, Minal A.
    Hoffman, Ronald
    BLOOD, 2019, 134
12345